Renalytix launches kidney disease test in Arabian Gulf countries

Renalytix announced the commercial availability of ‘kidneyintelX.dkd’ testing in six Gulf Cooperation Council (GCC) markets on Friday - Saudi Arabia, Bahrain, Qatar, Oman, Kuwait, and the United Arab Emirates.

Related Keywords

United States ,Tom Mclain ,Vector Pharma ,Renalytix ,Launches ,Kidney ,Disease ,Test ,Arabian ,Gulf ,Countries ,Category All ,Category Market Report ,Category Company News ,Category News And Announcements ,Category Small Caps News ,Category Aim Bulletin ,Category Market Pulse ,Mostread Small Caps ,